Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPFIB scaffold protein 2 (PPFIBP2), also known as liprin-beta-2, is a member of the liprin family of scaffold proteins that participate in organizing multiprotein complexes, particularly at synaptic sites and focal adhesions[6][5][9]. PPFIBP2 acts as a scaffold in neuronal development, playing a central role in the recruitment and spatial organization of receptor-type protein tyrosine phosphatases, such as LAR and its relatives, to the plasma membrane, thereby influencing axon guidance and synapse formation[5][6][9]. In addition to its developmental functions, PPFIBP2 has been implicated in disease processes: it acts as a tumor suppressor in some cancer types and has been identified as a fusion partner with several oncogenic kinases and phosphatases, suggesting potential relevance to cancer progression and prognosis[4]. While the protein is not a typical direct therapeutic target such as a receptor or enzyme, alterations in its expression or genetic status may have clinical utility as a biomarker in oncology[4][6]. No drugs specifically target PPFIBP2, nor are there established mechanisms of action or reported safety concerns associated with its modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PPFIB scaffold protein 2 (PPFIBP2).